NPS Pharmaceuticals (NPSP +04%) says the FDA has approved Gattex for the treatment of adult patients with short bowel syndrome who are dependent on parenteral support. The company says Gattex will be available in Q113.
Sent to 3,304 people who get email alerts on NPSP.
Get email alerts on NPSP »
Want to be faster and smarter on all your stocks?
Upgrade all your basic real-time alerts to PRO Alerts, for $20.